US Federal Courts Can Operate Until Jan. 25; Patent Office Faces Eminent Closure Under Shutdown
Executive Summary
Federal courts and USPTO will soon run out of funds that have allowed them to continue normal operations; pending ANDAs to get same filing date, which could lead to FDA legal challenges.
You may also be interested in...
ANDA Review: Moving From Tentative To Final Approval Could Require 10 Months Or More
US FDA draft guidance says substantive changes to reference product may require major ANDA amendment and 10-month review goal for the generic.
FDA's Post-Shutdown ANDA Bolus Could Be Massive
More than 300 generic drug applications might be officially filed when the shutdown ends, substantially increasing stress on assessors and other Office of Generic Drugs staff.
US FDA Shuttering More Operations As User Fee Money Dwindles
Compounding carryover money runs out, crippling some activities although inspections will continue; countdown to the end of PDUFA fee balance continues.